Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
NL0012768675
Mon, 13.11.2023       IGEA Pharma N.V.
NL0012768675

IGEA announces annual General Meeting Resolutions   Hoofddorp, the Netherlands, 13 November 2023. IGEA Pharma N.V. (SIX: IGPH) announced the annual General Meeting Resolution.   Hoofddorp, the Netherlands, 13 November 2023. IGEA Pharma N.V. (SIX: IGPH) today announced that the Annual General Meeting approved all the agenda resolutions. The min [ … ]
Technical analysis
To the publication
Mon, 09.10.2023       IGEA Pharma N.V.
NL0012768675

    FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, AUSTRALIA, CANADA, OR JAPAN     IGEA to update on RBCARE business combination Hoofddorp, the Nethe [ … ]
Technical analysis
To the publication
Tue, 03.10.2023       IGEA Pharma N.V.
NL0012768675

    FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, AUSTRALIA, CANADA, OR JAPAN     IGEA and RBCARE2023 signed to combine their businesses Hoofddorp,  [ … ]
Technical analysis
To the publication
Sat, 30.09.2023       IGEA Pharma N.V.
NL0012768675

IGEA discloses its half-year figures 2023   Hoofddorp, the Netherlands, 30 September2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its unaudited interim financial statements as of 30 June 2023.   Overview The Group discontinued in 2023 the industrial processing business as well as certain activities of the distribution segment  [ … ]
Technical analysis
To the publication
Thu, 28.09.2023       IGEA Pharma N.V.
NL0012768675

Convening notice 28 SEPTEMBER 2023 Dear Shareholder, The board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) hereby invites you to attend the Annual General Meeting on 09.11.2023 (the “AGM”) that will take place at Tribes Amsterdam South Axis FOZ, Gustav Mahlerlaan 308, 1082 ME Amsterdam, the Netherlands. The meeting will start at  [ … ]
Technical analysis
To the publication
Wed, 30.08.2023       IGEA Pharma N.V.
NL0012768675

IGEA filed the appeal on SIX decision of delisting   Hoofddorp, the Netherlands, 30 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the filing of the appeal to the decision of the SIX to delist the company.   The board of directors, through his Lawyers,  filed on August 28 its appeal to the decision of SIX to delist the company . As a [ … ]
Technical analysis
To the publication
Fri, 04.08.2023       IGEA Pharma N.V.
NL0012768675

IGEA to update on SIX decision   Hoofddorp, the Netherlands, 4 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the intention to appeal the decision of the SIX to delist the company.   The new board of directors entered in charge by end of April 2023 acted immediately to grant continuation of the activities and to respect any publicati [ … ]
Technical analysis
To the publication
Mon, 31.07.2023       IGEA Pharma N.V.
NL0012768675

IGEA discloses its Annual Report 2022   Hoofddorp, the Netherlands, 30 July 2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its Annual Report 2022.   Overview 2022 The Group did not start to generate revenue in the ‘Industrial processing’ segment as expected (same as previous period) and the ‘Distribution’ segment did not operat [ … ]
Technical analysis
To the publication
Mon, 31.07.2023       IGEA Pharma N.V.
NL0012768675

IGEA discloses its Annual Report 2022   Hoofddorp, the Netherlands, 30 July 2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its Annual Report 2022.   Overview 2022 The Group did not start to generate revenue in the ‘Industrial processing’ segment as expected (same as previous period) and the ‘Distribution’ segment did not operat [ … ]
Technical analysis
To the publication
Wed, 31.05.2023       IGEA Pharma N.V.
NL0012768675

      IGEA to apply for a further extension of its disclosure obligations   Hoofddorp, the Netherlands, 31 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the submission of a further exemption application to the SIX.   The exemption application, dated 31 May 2023, requests an extension of the deadline to publish IGEA’s 2022 annual rep [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 21.09.2024, Calendar Week 38, 265th day of the year, 101 days remaining until EoY.